Interaction of cigarette smoking and carcinogen-metabolizing polymorphisms in the risk of colorectal polyps

Carcinogenesis

Volumn 34, Issue 4, 2013, Pages 779-786

  Fu, Zhenming ^a   Shrubsole, Martha J ^a,b,c   Li, Guoliang ^a   Smalley, Walter E ^b,d   Hein, David W ^e   Cai, Qiuyin ^a   Ness, Reid M ^b,d   Zheng, Wei ^a,b,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Education and Clinical Center   (United States)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN;

ADULT; ARTICLE; CASE CONTROL STUDY; COLORECTAL ADENOMA; COLORECTAL POLYP; CONTROLLED STUDY; FEMALE; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TELECONSULTATION;

ADENOMA; ADULT; AGED; CARCINOGENS; CASE-CONTROL STUDIES; COLONIC POLYPS; COLORECTAL NEOPLASMS; DISEASE SUSCEPTIBILITY; ENZYMES; FEMALE; GENOTYPE; HUMANS; HYPERPLASIA; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK; RISK FACTORS; SMOKING; TOBACCO; TOBACCO SMOKE POLLUTION;

EID: 84875930639     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs410     Document Type: Article

References (60)

1. Botteri,E. et al.. (2008) Smoking and colorectal cancer: a meta-analysis. JAMA, 300, 2765-2778.
2. Edoardo,B. et al.. (2008) Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology, 134, 388-395.e3.
3. Muto,T. et al.. (1975) The evolution of cancer of the colon and rectum. Cancer, 36, 2251-2270.
4. Stryker,S.J. et al.. (1987) Natural history of untreated colonic polyps. Gastroenterology, 93, 1009-1013.
5. Fearon,E.R. et al.. (1990) A genetic model for colorectal tumorigenesis. Cell, 61, 759-767.
6. Hawkins,N.J. et al.. (2001) Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J. Natl. Cancer Inst., 93, 1307-1313.
7. Leggett,B. et al.. (2010) Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology, 138, 2088-2100.
8. Chu,D.Z. et al.. (1986) The significance of synchronous carcinoma and polyps in the colon and rectum. Cancer, 57, 445-450.
9. Kellokumpu,I. et al.. (1991) Multiple adenomas and synchronous hyperplastic polyps as predictors of metachronous colorectal adenomas. Ann. Chir. Gynaecol., 80, 30-35.
10. Hecht,S.S. (2003) Tobacco carcinogens, their biomarkers and tobaccoinduced cancer. Nat. Rev. Cancer, 3, 733-744.
11. Nebert,D.W. (1991) Role of genetics and drug metabolism in human cancer risk. Mutat. Res., 247, 267-281.
12. Fujii-Kuriyama,Y. et al.. (2005) Molecular mechanisms of AhR functions in the regulation of cytochrome P450 genes. Biochem. Biophys. Res. Commun., 338, 311-317.
13. Shrubsole,M.J. et al.. (2008) Alcohol drinking, cigarette smoking, and risk of colorectal adenomatous and hyperplastic polyps. Am. J. Epidemiol., 167, 1050-1058.
14. Fu,Z. et al.. (2011) Association of meat intake and meat-derived mutagen exposure with the risk of colorectal polyps by histologic type. Cancer Prev. Res. (Phila)., 4, 1686-1697.
15. Zheng,W. et al.. (2009) Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat. Genet., 41, 324-328.
16. Madure,M. et al.. (1992) Tests for trend and dose response: misinterpretations and alternatives. Am. J. Epidemiol., 135, 96-104.
17. Ulrich,C.M. et al.. (2001) Epoxide hydrolase Tyr113His polymorphism is associated with elevated risk of colorectal polyps in the presence of smoking and high meat intake. Cancer Epidemiol. Biomarkers Prev., 10, 875-882.
18. Ishibe,N. et al.. (2002) Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomas. Pharmacogenetics, 12, 145-150.
19. Chan,A.T. et al.. (2004) A prospective study of genetic polymorphisms in the cytochrome P-450 2C9 enzyme and the risk for distal colorectal adenoma. Clin. Gastroenterol. Hepatol., 2, 704-712.
20. Tiemersma,E.W. et al.. (2004) Risk of colorectal adenomas in relation to meat consumption, meat preparation, and genetic susceptibility in a Dutch population. Cancer Causes Control, 15, 225-236.
21. Goode,E.L. et al.. (2007) Inherited variation in carcinogen-metabolizing enzymes and risk of colorectal polyps. Carcinogenesis, 28, 328-341.
22. Shin,A. et al.. (2008) Meat intake, heterocyclic amine exposure, and metabolizing enzyme polymorphisms in relation to colorectal polyp risk. Cancer Epidemiol. Biomarkers Prev., 17, 320-329.
23. Wang,H. et al.. (2011) Genetic variation in the bioactivation pathway for polycyclic hydrocarbons and heterocyclic amines in relation to risk of colorectal neoplasia. Carcinogenesis, 32, 203-209.
24. Welfare,M.R. et al.. (1997) Relationship between acetylator status, smoking, and diet and colorectal cancer risk in the north-east of England. Carcinogenesis, 18, 1351-1354.
25. Chen,J. et al.. (1998) A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. Cancer Res., 58, 3307-3311.
26. Le Marchand,L. et al.. (2001) Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk. Cancer Epidemiol. Biomarkers Prev., 10, 1259-1266.
27. Le Marchand,L. et al.. (2002) Well-done red meat, metabolic phenotypes and colorectal cancer in Hawaii. Mutat. Res., 506-507, 205-214.
28. Tiemersma,E.W. et al.. (2002) Meat consumption, cigarette smoking, and genetic susceptibility in the etiology of colorectal cancer: results from a Dutch prospective study. Cancer Causes Control, 13, 383-393.
29. Barrett,J.H. et al.. ; Colorectal Cancer Study Group. (2003) Investigation of interaction between N-acetyltransferase 2 and heterocyclic amines as potential risk factors for colorectal cancer. Carcinogenesis, 24, 275-282.
30. Butler,L.M. et al.. (2005) Joint effects between UDP-glucuronosyltransferase [1A7] genotype and dietary carcinogen exposure on risk of colon cancer. Cancer Epidemiol. Biomarkers Prev., 14, 1626-1632.
31. Chan,A.T. et al.. (2005) Prospective study of N-acetyltransferase-2 genotypes, meat intake, smoking and risk of colorectal cancer. Int. J. Cancer, [115,] 648-652.
32. Lilla,C. et al.. (2006) Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption. Cancer Epidemiol. Biomarkers Prev., 15, 99-107.
33. Kury,S. et al.. (2007) Combinations of cytochrome P450 gene polymorphisms enhancing the risk for sporadic colorectal cancer related to red meat consumption. Cancer Epidemiol. Biomarkers Prev., 16, 1460-1467.
34. Butler,L.M. et al.. (2008) Modification by N-acetyltransferase 1 genotype on the association between dietary heterocyclic amines and colon cancer in a multiethnic study. Mutat. Res., 638, 162-174.
35. Cotterchio,M. et al.. (2008) Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk. Cancer Epidemiol. Biomarkers Prev., 17, 3098-3107.
36. Nothlings,U. et al.. (2009) Meat and heterocyclic amine intake, smoking, NAT1 and NAT2 polymorphisms, and colorectal cancer risk in the multiethnic cohort study. Cancer Epidemiol. Biomarkers Prev., 18, 2098-2106.
37. Moore,L.E. et al.. (2011) GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis. Carcinogenesis, [32,] 182-189.
38. Le Marchand,L. (2005) The predominance of the environment over genes in cancer causation: implications for genetic epidemiology. Cancer Epidemiol. Biomarkers Prev., 14, 1037-1039.
39. Smith,G.D. et al.. (2004) Mendelian randomization: prospects, potentials, and limitations. Int. J. Epidemiol., 33, 30-42.
40. Tobin,M.D. et al.. (2004) Commentary: development of Mendelian randomization: from hypothesis test to 'Mendelian deconfounding'. Int. J. Epidemiol., 33, 26-29.
41. Thanassoulis,G. et al.. (2009) Mendelian randomization: nature's randomized trial in the post-genome era. JAMA, 301, 2386-2388.
42. Benn,M. et al.. (2011) Low-density lipoprotein cholesterol and the risk of cancer: a mendelian randomization study. J. Natl. Cancer Inst., 103, 508-519.
43. Smith,G.D. Mendelian randomization for strengthening causal inference in observational studies. Perspect. Psychol. Sci., 5, 527-545.
44. Thomas,D.C. et al.. (2004) Commentary: the concept of 'Mendelian Randomization'. Int. J. Epidemiol., 33, 21-25.
45. Sachse,C. et al.. (1999) Functional significance of a C->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br. J. Clin. Pharmacol., 47, 445-449.
46. Landi,M.T. et al.. (2005) CYP1A1 and CYP1B1 genotypes, haplotypes, and TCDD-induced gene expression in subjects from Seveso, Italy. Toxicology, [207,] 191-202.47
47. Catalytic properties of polymorphic human cytochrome P450 1B1 variants
48. Crespi,C.L. et al.. (1997) The R144C change in the CYP2C9z.ast;2 allele alters interaction of the cytochrome P450 with NADPH:cytochrome P450 oxidoreductase. Pharmacogenetics, 7, 203-210.
49. Takanashi,K. et al.. (2000) CYP2C9 Ile359 and Leu359 variants: enzyme kinetic study with seven substrates. Pharmacogenetics, 10, 95-104.
50. Hayashi,S. et al.. (1991) Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J. Biochem., 110, 559-565.
51. Liu,Y. et al.. (2009) Genetic polymorphism and mRNA levels of cytochrome P450IIE1 and glutathione S-transferase P1 in patients with alcoholic liver disease in different nationalities. HBPD INT, 8, 162-167.
52. Hein,D.W. (2002) Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat. Res., 506-[507,] 65-77.
53. Metry,K.J. et al.. (2010) Effect of rapid human N-acetyltransferase 2 haplotype on DNA damage and mutagenesis induced by 2-amino-3-methylimidazo-[ 4,5-f]quinoline (IQ) and 2-amino-3,8-dimethylimidazo-[4,5-f] quinoxaline (MeIQx). Mutat. Res., 684, 66-73.
54. Hassett,C. et al.. (1994) Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum. Mol. Genet., 3, 421-428.
55. Raftogianis,R.B. et al.. (1997) Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype. Biochem. Biophys. Res. Commun., 239, 298-304.
56. Raftogianis,R.B. et al.. (1999) Human phenol sulfotransferases SULT1A2 and SULT1A1: genetic polymorphisms, allozyme properties, and human liver genotype-phenotype correlations. Biochem. Pharmacol., 58, 605-616.
57. Villeneuve,L. et al.. (2003) Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10-hydroxycamptothecin and flavopiridol anticancer drugs. J. Pharmacol. Exp. Ther., 307, 117-128.
58. Seidegard,J. et al.. (1988) Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc. Natl. Acad. Sci. U.S.A., 85, 7293-7297.
59. Josephy,P.D. (2010) Genetic variations in human glutathione transferase enzymes: significance for pharmacology and toxicology. Hum. Genomics Proteomics, 2010, 876940.
60. Hein,D.W. (2006) N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk. Oncogene, 25, 1649-1658.